Related Experiment Video
Updated: Jul 17, 2026

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
Somatic mutation detection efficiency in EGFR: a comparison between high resolution melting analysis and Sanger
Reenu Anne Joy1, Sukrishna Kamalasanan Thelakkattusserry1, Narendranath Vikkath1
1Molecular Oncology Diagnostics Laboratory, Amrita Institute of Medical Sciences, Amrita Vishwa Vidyapeetham, Kochi, 682041, India.
High-Resolution Melt Analysis (HRM) offers a sensitive method for detecting EGFR somatic mutations in non-small cell lung cancer. While HRM shows higher sensitivity than Sanger sequencing, confirmation with Sanger sequencing is recommended for accurate mutation detection.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- High-resolution melt (HRM) analysis is a rapid, cost-effective screening tool for somatic gene mutations.
- Previous studies explored HRM performance, but analytical parameters like limit of detection (LOD) and DNA concentration were not fully addressed.
- This study compares HRM and Sanger sequencing for detecting EGFR somatic mutations in non-small cell lung cancer (NSCLC).
Purpose of the Study:
- To compare the mutation detection efficiency of HRM and Sanger sequencing for EGFR somatic mutations.
- To determine the limit of detection for mutant allele fraction and total DNA concentration using both methods.
- To evaluate HRM's analytical performance against Sanger sequencing in NSCLC tumor tissues.
Main Methods:
- Sanger sequencing and HRM were used to determine the limit of detection of minor allele fraction against total DNA concentration.
- Multiplex allele-specific real-time PCR validated mutant and wildtype allele fractions.
- EGFR exons 19 and 21 mutation detection efficiency was compared in 116 FFPE tumor tissues, following screening of 275 tissues by Sanger sequencing.
Main Results:
- HRM detected lower minor allele fractions (0.25%) than Sanger sequencing (1%) for exon 19 EGFR mutations.
- Both methods detected 0.25% minor allele fraction for exon 21 mutations.
- HRM identified additional mutations not detected by Sanger sequencing (28% in exon 19, 40% in exon 21), with 100% sensitivity and 67% specificity.
Conclusions:
- HRM serves as a valuable initial screening test for EGFR somatic mutations in NSCLC.
- Sanger sequencing is essential for confirming HRM-detected mutations.
- Optimizing PCR annealing temperature could enhance Sanger sequencing's limit of detection.

